Phathom Pharmaceuticals, Inc. Quarterly Cost of Revenue in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2023 to Q3 2024.
  • Phathom Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $2.36M.
  • Phathom Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $4.33M.
  • Phathom Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $167K.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.33M $2.36M +$2.36M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.97M $1.38M +$1.38M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $593K $426K +$426K Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 $167K $167K Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.